GSK and Sanofi begin human trials of coronavirus vaccine September 3, 2020 Glaxosmithkline (GSK) has today announced that it is beginning human trials of the coronavirus vaccine it is developing with French pharma firm Sanofi. The two joined forces back in April to develop the potential vaccine, testing of which is now ready to move to the next stage after promising initial results. The combined phase 1 [...]
GSK sales fall as vaccine demand slumps during lockdown July 29, 2020 Revenue at drugs giant Glaxosmithkline (GSK) fell below analyst expectations today as sales of its blockbuster Shingles vaccine contracted sharply in the second quarter. Turnover dropped three per cent to £7.6bn, a little below forecasts of £7.7bn, while earnings per share fell back to 19.2p, lower than the 20.1p predicted. Shares in the FTSE 100 [...]
GSK plans to make 1bn coronavirus vaccine booster shots May 28, 2020 Drug giant Glaxosmithkline (GSK) today announced that it would aim to produce 1bn vaccine booster shots next year in a bid to improve the efficacy of potential new coronavirus treatments. These booster shots, which are called adjuvants, are a key part of vaccine development as they help patients develop a longer lasting immunity to disease. [...]
GSK beats expectations with strong first quarter performance April 29, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) beat analysts’ expectations with its first quarter results today, and said it remained on course to fulfil its 2020 guidance. The performance, which the firm labelled “strong”, was founded on high demand for its shingles treatment shingrix and higher sales of pain medications during the coronavirus crisis. GSK shares were flat [...]
Coronavirus: GSK chief urges drug firms to work together to develop vaccines April 15, 2020 The chief executive of pharmaceuticals giant Glaxosmithkline (GSK) has urged companies to join together to speed the development of a coronavirus vaccine, warning that the world will need more than one treatment for the disease. Emma Walmsley’s words came after the firm announced it had partnered with French drugmaker Sanofi to make a vaccine. Clinical [...]
GSK partners with Sanofi to develop coronavirus vaccine April 14, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has joined forces with French drugmaker Sanofi to develop a vaccine for the coronavirus disease. The two firms said that they were planning to begin clinical trials for the new treatment in the second half of this year. If successful, it is hoped that the vaccine would become available in the [...]
Pharma giant GSK takes $250m stake in firm to develop coronavirus vaccine April 7, 2020 Pharmaceuticals giant Glaxosmithkline (GSK) has taken a $250m (£202.7m) stake in an American biotech company in a collaborative effort to make a vaccine for Covid-19. Vir Biotechnology, of which GSK now owns a 6 per cent stake, specialises in the treatment of severe infectious diseases, and is looking to develop an antibody treatment for the [...]
Unilever acquires Horlicks brand in India in £397m deal April 1, 2020 Consumer goods giant Unilever has today completed the acquisition of Horlicks and other Glaxosmithkline brands in a £397m deal. The deal will allow Unilever to use the Horlicks brand rights and other GSK Consumer Healthcare nutrition brands in predominantly Asian markets. The company’s listed subsidiary in India, Hindustan Unilever Limited (Hul) also announced today that [...]
GSK falls short of forecasts as firm prepares to split February 5, 2020 Multinational drug firm Glaxosmithkline (GSK) saw a small rise in operating profit and earnings in 2019 as the firm announced it had begun its planned split into two companies following its venture with Pfizer. However, earnings per share fell short of analyst expectations at 123.9p, below consensus estimates of 125p. Pressure on the price of [...]
Glaxosmithkline posts third-quarter sales growth after Pfizer purchase October 30, 2019 Glaxosmithkline have reported group sales of £9.4bn for the third quarter, with total operating profits of £2.1m, compared with £1.9m for the same period in 2018. The drug manufacturer raised its forecast for 2019, saying that it now expected profits to be flat compared to last year, up from a previous estimated of a three [...]